Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pihlajamäki

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Diabetes|September 28, 2001
A major gene effect on fasting insulin and insulin sensitivity in familial combined hyperlipidemiaJ Pihlajamäki, M Austin, K Edwards, et al.
Chest|June 19, 1998
Effect of cold air on exercise capacity in COPD: increase or decrease?H Koskela, J Pihlajamäki, H Pekkarinen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 1998
Impaired insulin-stimulated glucose oxidation and free fatty acid suppression in patients with familial combined hyperlipidemia: a precursor defect for dyslipidemia?L Karjalainen, J Pihlajamäki, P Karhapää, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 1, 1997
Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemiaJ Pihlajamäki, J Rissanen, S Heikkinen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 15, 2000
Impaired free fatty acid suppression during hyperinsulinemia is a characteristic finding in familial combined hyperlipidemia, but insulin resistance is observed only in hypertriglyceridemic patientsJ Pihlajamäki, L Karjalainen, P Karhapää, et al.
European Journal of Clinical Investigation|April 12, 2001
The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistanceJ Pihlajamäki, R Valve, L Karjalainen, et al.
Metabolism: Clinical and Experimental|November 24, 1998
Different regulation of free fatty acid levels and glucose oxidation by the Trp64Arg polymorphism of the beta3-adrenergic receptor gene and the promoter variant (A-3826G) of the uncoupling protein 1 gene in familial combined hyperlipidemiaJ Pihlajamäki, J Rissanen, R Valve, et al.
European Journal of Psychotraumatology|July 15, 2014
Framework of the outreach after a school shooting and the students perceptions of the provided supportTuija Turunen, Henna Haravuori, Jaakko J Pihlajamäki, et al.
Atherosclerosis|June 28, 2001
Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart diseaseL Viitanen, J Pihlajamäki, P Halonen, et al.
Journal of Internal Medicine|September 14, 2010
Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemiasP Karhapää, J Pihlajamäki, I Pörsti, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Diabetes|September 28, 2001
A major gene effect on fasting insulin and insulin sensitivity in familial combined hyperlipidemiaJ Pihlajamäki, M Austin, K Edwards, et al.
Chest|June 19, 1998
Effect of cold air on exercise capacity in COPD: increase or decrease?H Koskela, J Pihlajamäki, H Pekkarinen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 1998
Impaired insulin-stimulated glucose oxidation and free fatty acid suppression in patients with familial combined hyperlipidemia: a precursor defect for dyslipidemia?L Karjalainen, J Pihlajamäki, P Karhapää, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 1, 1997
Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemiaJ Pihlajamäki, J Rissanen, S Heikkinen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 15, 2000
Impaired free fatty acid suppression during hyperinsulinemia is a characteristic finding in familial combined hyperlipidemia, but insulin resistance is observed only in hypertriglyceridemic patientsJ Pihlajamäki, L Karjalainen, P Karhapää, et al.
European Journal of Clinical Investigation|April 12, 2001
The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistanceJ Pihlajamäki, R Valve, L Karjalainen, et al.
Metabolism: Clinical and Experimental|November 24, 1998
Different regulation of free fatty acid levels and glucose oxidation by the Trp64Arg polymorphism of the beta3-adrenergic receptor gene and the promoter variant (A-3826G) of the uncoupling protein 1 gene in familial combined hyperlipidemiaJ Pihlajamäki, J Rissanen, R Valve, et al.
European Journal of Psychotraumatology|July 15, 2014
Framework of the outreach after a school shooting and the students perceptions of the provided supportTuija Turunen, Henna Haravuori, Jaakko J Pihlajamäki, et al.
Atherosclerosis|June 28, 2001
Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart diseaseL Viitanen, J Pihlajamäki, P Halonen, et al.
Journal of Internal Medicine|September 14, 2010
Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemiasP Karhapää, J Pihlajamäki, I Pörsti, et al.
Pageof 4